Berkeley Lovelace Jr.

Berkeley Lovelace Jr.

Berkeley Lovelace Jr. is a health medical reporter for NBC News. He reports on the Food and Drug Administration, with a particular emphasis on Covid vaccines, pricing of prescription drugs and health care. Previously, he reported on the biotech and pharmaceutical industry for CNBC.

Claims from Berkeley Lovelace Jr.

Berkeley Lovelace Jr.
Berkeley Lovelace Jr."Thanks largely to loopholes in the U.S. patent system, Americans aren’t expected to get generic forms of semaglutide, the drug in Novo Nordisk’s Ozempic and Wegovy, until at least the end of 2031."May 13, 2026

Controversy:Will Semaglutide Biosimilars or Generics Become Available in the US Market Before 2032?

NBC
NBC
Home
Bias Split
Sources
Controversies

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!
AboutContact UsNewsletter ArchiveMedia
FAQGlossaryVerity EdPrivacy Policy
© 2026 Improve the News Foundation. All rights reserved.Version 7.7.3

© 2026 Improve the News Foundation.

All rights reserved.

Version 7.7.3